Immune surveillance of unhealthy cells by natural killer cells

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 78, Issue 1, 2013, Pages 249-257

  Iannello, Alexandre ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; LIGAND; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN; PROTEIN P53; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; TP53 PROTEIN, HUMAN;

ARTICLE; CANCER INHIBITION; DNA DAMAGE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; MALIGNANT NEOPLASTIC DISEASE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; TUMOR CELL; ANIMAL; CELL AGING; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MOUSE; NEOPLASM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; CELL AGING; HUMANS; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTES; MICE; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84904861169     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2013.78.020255     Document Type: Article

References (60)

1. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
2. Bauman Y, Nachmani D, Vitenshtein A, Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R, Mandelboim O. 2011. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 9: 93-102.
3. Braig M, Schmitt CA. 2006. Oncogene-induced senescence:Putting the brakes on tumor development. Cancer Res 66:2881-2884.
4. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665.
5. Braumuller H, Wieder T, Brenner E, Assmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Gries-singer C, et al. 2013. T-helper-1-cell cytokines drive cancer into senescence. Nature 494: 361-365.
6. Campisi J. 2013. Aging, cellular senescence, and cancer. Annu Rev Physiol 75: 685-705.
7. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. 2007. Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110: 606-615.
8. Cerwenka A, Bakker AB, McClanahan T, Wagner J, Wu J, Phillips JH, Lanier LL. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12: 721-727.
9. Cerwenka A, Baron JL, Lanier LL. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci 98: 11521-11526.
10. Collado M, Serrano M. 2010. Senescence in tumours: Evidence from mice and humans. Nat Rev Cancer 10: 51-57.
11. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. 2000. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 1: 119-126.
12. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature 413: 165-171.
13. Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, Davis DM. 2010. Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol 184:6901-6909.
14. Gasser S, Raulet DH. 2006. The DNA damage response arouses the immune system. Cancer Res 66: 3959-3962.
15. Gasser S, Orsulic S, Brown EJ, Raulet DH. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
16. Gourzi P, Leonova T, Papavasiliou FN. 2006. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24: 779-786.
17. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci 93: 12445-12450.
18. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. 1999. Broad tumor-associated expression and recognition by tumor-derived gd T cells of MICA and MICB. Proc Natl Acad Sci 96: 6879-6884.
19. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, Knoblaugh S, Cado D, Greenberg NM, Raulet DH. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 28: 571-580.
20. Hacke K, Rincon-Orozco B, Buchwalter G, Siehler SY, Wasylyk B, Wiesmuller L, Rosl F. 2010. Regulation of MCP-1 chemokine transcription by p53. Mol Cancer 9: 82.
21. Hamerman JA, Ogasawara K, Lanier LL. 2004. Cutting edge:Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 172: 2001-2005.
22. Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH. 2013. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med 210: 2057-2069.
23. Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH. 2012. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J Exp Med 209: 2409-2422.
24. Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A, et al. 2011. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479: 547-551.
25. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. 2008. Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
26. Lanier LL. 2005. NK cell recognition. Annu Rev Immunol 23:225-274.
27. Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, Szekely L, Karre K, Carbone E, Selivanova G. 2011. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle 10: 3346-3358.
28. Lin D, Lavender H, Soilleux EJ, O'Callaghan CA. 2012. NF- κB regulates MICA gene transcription in endothelial cell through a genetically inhibitable control site. J Biol Chem 287: 4299-4310.
29. Liu XV, Ho SS, Tan JJ, Kamran N, Gasser S. 2012. Ras activation induces expression of Raet1 family NK receptor ligands. J Immunol 189: 1826-1834.
30. Lopez-Soto A, Quinones-Lombrana A, Lopez-Arbesu R, Lopez-Larrea C, Gonzalez S. 2006. Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor. J Biol Chem 281: 30419-30430.
31. Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, et al. 2013. Non-cell-autonomous tumor suppression by p53. Cell 153: 449-460.
32. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724.
33. Molinero LL, Fuertes MB, Girart MV, Fainboim L, Rabinovich GA, Costas MA, Zwirner NW. 2004. NF-κB regulates expression of the MHC class I-related chain A gene in activated T lymphocytes. J Immunol 173: 5583-5590.
34. Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O. 2009. Diverse herpes virus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
35. Narita M, Nunez S, Heard E, Lin AW, Hearn SA, Spector DL, Hannon GJ, Lowe SW. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703-716.
36. Nice TJ, Coscoy L, Raulet DH. 2009. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J Exp Med 206: 287-298.
37. Nice TJ, Deng W, Coscoy L, Raulet DH. 2010. Stress-regulated targeting of the NKG2D ligand Mult1 by a membrane-associated RING-CH family E3 ligase. J Immunol 185: 5369-5376.
38. Norman JM, Mashiba M, McNamara LA, Onafuwa-Nuga A, Chiari-Fort E, Shen W, Collins KL. 2011. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat Immunol 12: 975-983.
39. Raulet DH. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3: 781-790.
40. Raulet DH, Guerra N. 2009. Oncogenic stress sensed by the immune system: Role of natural killer cell receptors. Nat Rev Immunol 9: 568-580.
41. Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. 2013. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31: 413-441.
42. Richard J, Sindhu S, Pham TN, Belzile JP, Cohen EA. 2010. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. Blood 115: 1354-1363.
43. Routes JM, Ryan S, Morris K, Takaki R, Cerwenka A, Lanier LL. 2005. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection. J Exp Med 202: 1477-1482.
44. INK4a. Cell 88: 593-602.
45. Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al. 2009. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood 113: 3503-3511.
46. Stern-Ginossar N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, et al. 2007. Host immune system gene targeting by a viral miRNA. Science 317: 376-381.
47. Stern-Ginossar N, Gur C, Biton M, Horwitz E, Elboim M, Stanietsky N, Mandelboim M, Mandelboim O. 2008. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol 9: 1065-1073.
48. Stewart SA, Weinberg RA. 2006. Telomeres: Cancer to human aging. Annu Rev Cell Dev Biol 22: 531-557.
49. Tang X, Asano M, O'Reilly A, Farquhar A, Yang Y, Amar S. 2012. p53 is an important regulator of CCL2 gene expression. Curr Mol Med 12: 929-943.
50. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. 2013. Cellular senescence and the senescent secretory phenotype:Therapeutic opportunities. J Clin Invest 123: 966-972.
51. Textor S, Fiegler N, Arnold A, Porgador A, Hofmann TG, Cerwenka A. 2011. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res 71: 5998-6009.
52. Tokuyama M, Lorin C, Delebecque F, Jung H, Raulet DH, Coscoy L. 2011. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3 K pathway during viral infection and transformation. PLoS Pathog 7:e1002265s.
53. Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. 2007. Promoter region architecture and transcriptional regulation of the genes for theMHCclass I-related chain A and B ligands of NKG2D. J Immunol 178: 961-969.
54. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. 2007. Restoration of p53 function leads to tumour regression in vivo. Nature 445: 661-665.
55. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. 2011. Innate or adaptive immunity? The example of natural killer cells. Science 331: 44-49.
56. Walzer T, Vivier E. 2011. G-protein-coupled receptors in control of natural killer cell migration. Trends Immunol 32: 486-492.
57. Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E. 2009. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog 5: e1000613s.
58. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656-660.
59. Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD. 2009. Cutting edge: Down-regulation of MHC class I-related chain A on tumor cells by IFN-γ-induced microRNA. J Immunol 182: 39-43.
60. Zilfou JT, Lowe SW. 2009. Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1: a001883.